CYP3A-inducing antiepileptics decrease sorafenib exposures: Results of a phase II study in adults with recurrent glioblastoma. Background: The apparent diffusion coefficient (ADC) obtained from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results